Jenny H. Robeson

Jenny (Hall) Robeson joined HIFU Prostate Services (HPS) in 2016 as chief sales officer and brings over 21 years of medical device, pharmaceutical and biotech sales experience to the company, including six years with SonaCare Medical, the manufacturer of the Sonablate HIFU system.

Most of her career has been focused on urology products and growing sales within the urology community and especially early adopters of new prostate cancer therapies and pharmaceuticals. As chief sales officer, Robeson is responsible for managing all of the sales efforts for HPS, identifying new training physicians and treatment facilities, and driving utilization through existing HIFU centers.

Prior to joining HPS, Robeson spent five years at Dendreon where she consistently ranked at the top of the organization in sales for the late-stage prostate cancer therapy, Provenge, as a corporate account manager. In 2015, Robeson ranked nationally as the #1 corporate account manager at Dendreon after ranking #3 in the nation in 2013 and 2014. From 2006 until 2012, Robeson was the top physician development specialist for SonaCare Medical driving $4 – $6 million of annual offshore HIFU revenue while introducing new users to the HIFU technology. Before joining SonaCare Medical, Robeson was a sales representative for GlaxoSmithKline selling Avodart for benign prostatic hyperplasia, or enlarged prostate. She has also worked for TAP Pharmaceuticals.

Robeson graduated from The UNC Gillings School of Global Public Health at The University of North Carolina at Chapel Hill with a B.S. in Human Nutrition and Biology. She also received a Master’s in Human Nutrition from Winthrop University.